Mitsubishi Tanabe

RADICAVA

Manufacturer:

Mitsubishi Tanabe

Radicava HCPCS:

J1301

HCPCS Code Descriptor:

Injection, edaravone, 1 mg

Category:

J Code

Radicava NDCs:

70510-2171-02

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Bag

Route of Administration:

Intravenous

Radicava CPT Codes:

Potential CPT administration codes for Radicava can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Radicava:

RADICAVA is a Neurology drug manufactured by Mitsubishi Tanabe and administered via the Intravenous route of administration. The J Code: J1301 is aligned to the drug RADICAVA.

ACCESS PRICING AND MORE BY REGISTERING

J1301 Added Date:

January 1, 2019

J1301 Effective Date:

January 1, 2019

J1301 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Radicava billing and coding information.
Radicava patient assistance information can be found through The JourneyMate Support Program at the URL: https://www.radicava.com/patient/support/journeymate-support-program/
RADICAVA prescribing information can be found at the link below:
Information regarding RADICAVA’s side effects can be found at MedlinePlus